NEW YORK (GenomeWeb) – Rosetta Genomics reported yesterday after the close of the market a more than 300 percent rise in revenues from continuing operations in the first half of 2015, reflecting the contribution of PersonalizeDx, a molecular diagnostics firm acquired in April.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.